# Cross Iron (Comparative Randomized Oral Versus Systemic IRON)

> **NCT02496377** · NA · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 100 (actual)

## Conditions studied

- Allogenic Transfusion
- Perioperative Anaemia
- Knee Arthroplasty
- Hip Arthroplasty

## Interventions

- **DRUG:** ferrous glycine sulfate Tardyferon
- **DRUG:** Epoetin Alfa
- **DRUG:** ferric carboxymaltose Ferinject

## Key facts

- **NCT ID:** NCT02496377
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-29
- **Primary completion:** 2016-10-16
- **Final completion:** 2016-10-16
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496377, "Cross Iron (Comparative Randomized Oral Versus Systemic IRON)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02496377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*